- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 664
Flowhub gets $23m top up
Kraft Heinz-backed Evolv Ventures has contributed to Flowhub's series A round to take the cannabis industry software producer's total funding to almost $27m.
Oct 17, 2019Yidebang treats itself to series B funding
Sinovation Ventures led a round for the Fosun-backed medical services platform developer that raised in excess of $14.1m in its series B round.
Oct 17, 2019Thimble covers series A round with $22m influx
IAC and Axa Venture Partners both invested in Verifly, which has rebranded to Thimble as it expands from drones to wider workplace insurance.
Oct 17, 2019Lovevery locks in $20m series B
GV supplied a share of the funding for early learning toy producer Lovevery, which will use the proceeds to expand its product range and functionality.
Oct 17, 2019Building Engines turns up the pace
Returning investors including MassMutual Ventures have added $12.7m to the $26.5m they helped to invest in the real estate management software developer three years ago.
Oct 17, 2019Wildcat hunts down $20m
The A123 Systems-backed battery materials tester has secured $20m in a series C round co-led by Flint Hills Resources that took its overall funding to more than $70m.
Oct 17, 2019Abalos attracts $13.3m series A
Spun out of University of Duisburg-Essen and University of Düsseldorf, Abalos has raised funding to kickstart development of arenavirus-based immunotherapies.
Oct 16, 2019Algolia reaches $110m goal in latest round
Salesforce Ventures contributed to a series C round that took the online search software provider's total funding past the $180m mark.
Oct 16, 2019Level Home lets in $71m
Walmart and Lennar both invested in the home automation technology developer, which has just unveiled its first product, a smart lock.
Oct 16, 2019Healx seals $56m series B
Intel Capital was among the participants in a round that lifted the total raised by rare disease-focused drug developer Healx to nearly $70m.
Oct 16, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


